Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London

Core Points - Terns Pharmaceuticals, Inc. is a clinical-stage oncology company that will present at the Jefferies Global Healthcare Conference in London on November 17, 2025 [1] - The presentation will be available via a live webcast on the company's investor relations page, with a replay archived for at least 30 days [2] - Terns' lead program, TERN-701, is a selective allosteric BCR-ABL inhibitor aimed at improving treatment for chronic myeloid leukemia (CML) [3]